References
Au WY, Ma SK, Ooi C, Liang R, Kwong YL (2000) Unusual manifestations of acute leukemia. Case 1. CNS extramedullary relapse of acute promyelocytic leukemia after arsenic trioxide-induced remission. J Clin Oncol 18:3435–3437
de Botton S, Sanz MA, Chevret S, Dombret H, Martin G, Thomas X et al (2006) Extramedullary relapse in acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Leukemia 20:35–41
Tse E, Yip SF, Ooi CG, Kwong YL (2006) Subarachnoid haemorrhage: more than meets the eye. Br J Haematol 132:383
Owonikoko T, Agha M, Balassanian R, Smith R, Raptis A (2007) Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant. Nat Clin Pract Oncol 4:491–495
Piccaluga RP, Martinelli G, Rondoni M, Malagola M, Gaitani S, Isidori A et al (2004) Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas. Leuk Lymphoma 45:1791–1795
Falanga A, Barbui T (2001) Coagulopathy of acute promyelocytic leukemia. Acta Haematol 106:43–51
Au WY, Tam S, Fong BM, Kwong YL (2006) Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia. Blood 107:3012–3013
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nagai, S., Asai, T., Watanabe, T. et al. Simultaneous appearance of central nervous system relapse and subarachnoid hemorrhage during the treatment for acute promyelocytic leukemia. Ann Hematol 87, 593–595 (2008). https://doi.org/10.1007/s00277-008-0436-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00277-008-0436-5